Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism? A Population-Based Case-Control Study

被引:102
|
作者
Heit, John A. [1 ,2 ]
Leibson, Cynthia L. [3 ]
Ashrani, Aneel A. [2 ]
Petterson, Tanya M. [4 ]
Bailey, Kent R. [4 ]
Melton, L. Joseph, III [3 ]
机构
[1] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Sect Vasc Dis,Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Internal Med, Div Hematol, Hematol Res Sect,Coll Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Coll Med, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Coll Med, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
venous thromboembolism; deep vein thrombosis; pulmonary embolism; diabetes mellitus; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; METABOLIC SYNDROME; DISEASE; HEART; EPIDEMIOLOGY;
D O I
10.1161/ATVBAHA.109.189290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Although diabetes mellitus is reported as a risk factor for venous thromboembolism (VTE), persons with diabetes are frequently hospitalized for medical illness or surgery, or confined to a nursing home, all major VTE risk factors. Consequently, we tested diabetes for an independent association with incident VTE. Methods and Results-Using Rochester Epidemiology Project resources, we identified all Olmsted County, Minn residents who met objective criteria for incident VTE over the 25-year period, 1976 to 2000 (n=1922), and 1 to 2 resident controls per case, matched on age, gender, and length of medical history (n=2115). Complete medical histories in the community were reviewed for previously identified independent VTE risk factors and diabetes-related variables. We tested diabetes and diabetes complications (retinopathy, nephropathy or neuropathy, and ketoacidosis) as potential VTE risk factors, both alone and after adjusting for VTE risk factors. Univariately, diabetes by clinical diagnosis or by stricter criteria (fasting ambulatory blood glucose >= 140 mg/dL or antidiabetic drug therapy), and diabetes complications, were associated with overall incident VTE. However, after controlling for hospitalization for major surgery or medical illness and nursing home confinement, diabetes was no longer associated with VTE. Conclusion-Diabetes mellitus and diabetes complications are not independent risk factors for incident VTE. (Arterioscler Thromb Vasc Biol. 2009;29:1399-1405.)
引用
收藏
页码:1399 / 1405
页数:7
相关论文
共 50 条
  • [1] Is Diabetes Mellitus An Independent Risk Factor for Incident Venous Thromboembolism (VTE)? a Population-Based Case-Control Study
    Heit, John A.
    Leibson, Cynthia L.
    Ashrani, Aneel A.
    Petterson, Tanya M.
    Bailey, Kent R.
    Melton, L. Joseph, III
    [J]. BLOOD, 2008, 112 (11) : 1306 - 1306
  • [2] Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study
    Cohoon, Kevin P.
    Ashrani, Aneel A.
    Crusan, Daniel J.
    Petterson, Tanya M.
    Bailey, Kent R.
    Heit, John A.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2018, 131 (03): : 307 - +
  • [3] Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study
    Barsoum, Michel K.
    Heit, John A.
    Ashrani, Aneel A.
    Leibson, Cynthia L.
    Petterson, Tanya M.
    Bailey, Kent R.
    [J]. THROMBOSIS RESEARCH, 2010, 126 (05) : 373 - 378
  • [4] Is progesterone an independent risk factor for incident venous thromboembolism (VTE)? a population-based case-control study
    Barsoum, M.
    Heit, J. A.
    Ashrani, A. A.
    Leibson, C. L.
    Petterson, T. M.
    Bailey, K. R.
    Melton, L. J., III
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 78 - 78
  • [5] Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study
    Ashrani, Aneel A.
    Barsoum, Michel K.
    Crusan, Daniel J.
    Petterson, Tanya M.
    Bailey, Kent R.
    Heit, John A.
    [J]. THROMBOSIS RESEARCH, 2015, 135 (06) : 1110 - 1116
  • [6] Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study
    Johannesdottir, Sigrun A.
    Horvath-Puho, Erzsebet
    Dekkers, Olaf M.
    Cannegieter, Suzanne C.
    Jorgensen, Jens Otto L.
    Ehrenstein, Vera
    Vandenbroucke, Jan P.
    Pedersen, Lars
    Sorensen, Henrik Toft
    [J]. CLINICAL OTOLARYNGOLOGY, 2013, 38 (05) : 379 - 379
  • [7] Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study
    Johannesdottir, Sigrun A.
    Horvath-Puho, Erzsebet
    Dekkers, Olaf M.
    Cannegieter, Suzanne C.
    Jorgensen, Jens Otto L.
    Ehrenstein, Vera
    Vandenbroucke, Jan P.
    Pedersen, Lars
    Sorensen, Henrik Toft
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (09) : 743 - 752
  • [8] Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study
    A. L. Lamberg
    E. Horvath-Puho
    S. Christensen
    H. T. Sørensen
    [J]. Osteoporosis International, 2010, 21 : 1911 - 1917
  • [9] Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study
    Lamberg, A. L.
    Horvath-Puho, E.
    Christensen, S.
    Sorensen, H. T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 (11) : 1911 - 1917
  • [10] Coeliac disease and risk of venous thromboembolism: a nationwide population-based case-control study
    Johannesdottir, Sigrun Alba
    Erichsen, Rune
    Horvath-Puho, Erzsebet
    Schmidt, Morten
    Sorensen, Henrik Toft
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 499 - 501